Cilansetron is an experimental drug that is a 5-HT3 antagonist under development by Solvay Pharmaceuticals.
Cilansetron is an experimental drug that is a 5-HT3 antagonist under development by Solvay Pharmaceuticals.
5-HT3 receptors are responsible for causing many things from nausea to excess bowel movements. In conditions such as irritable bowel syndrome (IBS), the receptors have become faulty or oversensitive. 5-HT3 antagonists work by blocking the nervous and chemical signals from reaching these receptors.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).